Part ofhealthcare →

HR5343FEDERALin_committee

High Impact

House committee advances bill to expedite Medicare coverage for breakthrough medical devices

Original title: Ensuring Patient Access to Critical Breakthrough Products Act

September 17, 2025

healthcare medical devices medicare federal legislation

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced

Committee

Floor Vote

Passed

Signed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.Sep 17, 2025

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

This bill directly impacts patients with serious or life-threatening conditions by potentially accelerating their access to cutting-edge medical devices that are currently delayed by separate Medicare coverage review processes.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Medicare beneficiaries

Patients may gain faster access to new medical technologies that receive breakthrough designation.

medical device manufacturers

Companies producing breakthrough devices may see a reduction in the time required to secure Medicare reimbursement.

Centers for Medicare & Medicaid Services

The agency is required to establish and manage the new expedited coverage pathway mandated by the bill.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

The Ensuring Patient Access to Critical Breakthrough Products Act requires the Centers for Medicare & Medicaid Services (CMS) to establish a streamlined pathway for Medicare coverage of medical devices designated as 'breakthrough' by the FDA. This measure aims to reduce the time between FDA approval and Medicare payment for new, innovative medical technologies.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

Frequently Asked Questions

What is a 'breakthrough' device?

A breakthrough device is a medical product that has received a specific designation from the FDA because it provides for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions.

How does this change current Medicare rules?

Currently, even after FDA approval, medical devices often undergo a separate, lengthy process by CMS; this bill requires a more direct and faster pathway for these specific innovative products.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Lobbying Activity

RS GROUP CONSULTING LLC

on behalf of INSIGHTEC, INC.

View filing →

RS GROUP CONSULTING LLC

on behalf of INSIGHTEC, INC.

View filing →

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Streamlining Coverage

The bill represents a shift toward automating Medicare coverage for products already vetted by the FDA as 'breakthrough' technologies.

Centers for Medicare & Medicaid Services FDA

Connected Entities

organizationFDA“The agency responsible for granting 'breakthrough' designation to medical device”Map →

organizationCenters for Medicare & Medicaid Services“The federal agency responsible for implementing the coverage pathway.”Map →

Analysis Score

0–100

Significance75
How much this matters to a regular citizen
Controversy40
Intensity of disagreement among stakeholders
Entertainment10
Compellingness for a non-policy-wonk reader
Buzz30
Current news / social attention level

Publisher tools